Significance of ALT/AST ratio for specifying subjects with metabolic syndrome in its silent stage

Hideki Ohgo, Hirokazu Yokoyama, Hiroshi Hirose, Hiroshi Kawabe, Ikuo Saito, Kengo Tomita, Toshifumi Hibi

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)


Aims: Association between metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD) was verified and significance of liver function tests, especially alanine aminotransferase/aspartate aminotransferase ratio (ALT/AST) to evaluate the statuses of MetS and/or visceral fat accumulation was examined. Materials and Methods: After excluding subjects with liver diseases other than NAFLD, 1643 male and 1764 female Japanese were cross-sectionally examined. The diagnosis of MetS was done by its clinical criteria for Japanese with some modifications. Results: Levels of AST, ALT, gamma glutamyl transpeptidase and ALT/AST were significantly higher in subjects with MS than in those without it. Stepwise regression analyses indicated that AST, ALT, and ALT/AST in male and ALT/AST in female were significantly associated with waist circumference (WC), a marker of visceral fat accumulation. Among these associations, the association between WC and ALT/AST was always significant even when subjects with normal level of ALT of WC were selectively examined. Conclusions: NAFLD can be considered as one of morbid conditions of MetS, i.e. visceral fat accumulation. Among liver function test items, ALT/AST could be a powerful index reflecting their progression even in their pre-diagnosis/silent phases.

Original languageEnglish
Pages (from-to)3-6
Number of pages4
JournalDiabetes and Metabolic Syndrome: Clinical Research and Reviews
Issue number1
Publication statusPublished - 2009 Jan


  • Metabolic syndrome
  • Non-alcoholic fatty liver disease
  • Visceral fat accumulation
  • Waist circumference

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'Significance of ALT/AST ratio for specifying subjects with metabolic syndrome in its silent stage'. Together they form a unique fingerprint.

Cite this